ArticleCancers2024

Use of Different Anti-PD-1 Checkpoint Combination Strategies for First-Line Advanced NSCLC Treatment-The Experience of Ion Chiricuță Oncology Institute.

Alexandra-Cristina Preda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.